Cytomorphology of gastrointestinal stromal tumor: Diagnostic role of aspiration cytology, core biopsy, and immunochemistry

2000 ◽  
Vol 23 (3) ◽  
pp. 156-160 ◽  
Author(s):  
Hugo E. Boggino ◽  
Martin P. Fernandez ◽  
Roberto Logro�o
Endoscopy ◽  
2017 ◽  
Vol 49 (S 01) ◽  
pp. E11-E13 ◽  
Author(s):  
Hejun Zhou ◽  
Yuyong Tan ◽  
Chunlian Wang ◽  
Jingbo Yang ◽  
Yuqian Zhou ◽  
...  

2009 ◽  
Vol 2 ◽  
pp. CGast.S3422
Author(s):  
Ka-Ho Lok

The treatment for localized advance gastrointestinal stromal tumor (GIST) is far from ideal. Up to 50% of patient developed post-operative recurrence and died within 5 years. Recently, imatinib was found to significantly improve recurrence-free survival in post-operative patients. The role of adjuvant therapy in high risk GIST patients is discussed.


Sign in / Sign up

Export Citation Format

Share Document